Clinical recommendations on lung cancer management during the COVID‐19 pandemic
Clinical recommendations on lung cancer management during the COVID‐19 pandemic
About this item
Full title
Author / Creator
Xu, Yan , Liu, Hongsheng , Hu, Ke and Wang, Mengzhao
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Subjects
More information
Scope and Contents
Contents
Coronavirus disease 2019 (COVID‐19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy. Furthermore, patients with cancer demonstrate p...
Alternative Titles
Full title
Clinical recommendations on lung cancer management during the COVID‐19 pandemic
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_57a5682345a1470c90c483c2ac4c22a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_57a5682345a1470c90c483c2ac4c22a8
Other Identifiers
ISSN
1759-7706,1759-7714
E-ISSN
1759-7714
DOI
10.1111/1759-7714.13498
